Details for Patent: 5,436,272
✉ Email this page to a colleague
Summary for Patent: 5,436,272
Title: | Treatment of obesity |
Abstract: | N,N-dimethyl-1-[ 1-(4-chlorophenyl)cyclobutyl] -3-methylbutylamine hydrochloride is used in the treatment of obesity in humans. |
Inventor(s): | Scheinbaum; Monte L. (Shreveport, LA) |
Assignee: | The Boots Company (USA), Inc. (Shreveport, IN) |
Application Number: | 07/962,175 |
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; |
Drugs Protected by US Patent 5,436,272
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,436,272
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0397831 | ⤷ Sign Up | SPC/GB01/053 200210 | United Kingdom | ⤷ Sign Up |
European Patent Office | 0397831 | ⤷ Sign Up | 01C0052 | France | ⤷ Sign Up |
European Patent Office | 0397831 | ⤷ Sign Up | SPC/GB01/053 | United Kingdom | ⤷ Sign Up |
European Patent Office | 0397831 | ⤷ Sign Up | 300066 | Netherlands | ⤷ Sign Up |
European Patent Office | 0397831 | ⤷ Sign Up | 34/2001 | Austria | ⤷ Sign Up |
Austria | 94385 | ⤷ Sign Up | |||
Australia | 4620789 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |